Page last updated: 2024-08-22

vasotocin and albuterol

vasotocin has been researched along with albuterol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cole, S; Flenady, V; Liley, H; Papatsonis, D	1
Advenier, C; Bardou, M; Breuiller-Fouché, M; Cecchi, R; Croci, T; Descamps, L; Fradin, Y; Germain, G; Guagnini, F; Leroy, MJ; Marini, P; Pascal, M; Rouget, C; Viviani, N	1
Flenady, V; Liley, HG; Papatsonis, DN; Reinebrant, HE; Tambimuttu, EG	1

Reviews

2 review(s) available for vasotocin and albuterol

Article	Year
Oxytocin receptor antagonists for inhibiting preterm labour. The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3 Topics: Albuterol; Female; Humans; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Receptors, Oxytocin; Ritodrine; Terbutaline; Tocolytic Agents; Vasotocin	2005
Oxytocin receptor antagonists for inhibiting preterm labour. The Cochrane database of systematic reviews, 2014, Jun-06, Issue:6 Topics: Albuterol; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Obstetric Labor, Premature; Oligopeptides; Pregnancy; Randomized Controlled Trials as Topic; Receptors, Oxytocin; Ritodrine; Terbutaline; Tocolytic Agents; Vasotocin	2014

Trials

2 trial(s) available for vasotocin and albuterol

Article	Year
Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG : an international journal of obstetrics and gynaecology, 2001, Volume: 108, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Female; Humans; Obstetric Labor, Premature; Pregnancy; Ritodrine; Terbutaline; Tocolytic Agents; Treatment Outcome; Vasotocin	2001
Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 98, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Female; Fetal Death; Hormone Antagonists; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Outcome; Uterine Contraction; Vasotocin	2001

Article

Year

Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.

BJOG : an international journal of obstetrics and gynaecology, 2001, Volume: 108, Issue:2

Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Female; Humans; Obstetric Labor, Premature; Pregnancy; Ritodrine; Terbutaline; Tocolytic Agents; Treatment Outcome; Vasotocin

2001

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.

European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 98, Issue:2

Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Female; Fetal Death; Hormone Antagonists; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Outcome; Uterine Contraction; Vasotocin

2001

Other Studies

1 other study(ies) available for vasotocin and albuterol

Article	Year
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:3 Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin	2007

Article

Year

In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni

The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:3

Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin

2007